{"F": {"ts_code": "US.EXEL", "name": "伊克力西斯", "mkt": "US", "ccy": "美元", "sw1": "生物技术", "sw2": "生物技术", "sw3": "", "ind": "生物技术", "fin_source": "futu", "market": "NASDAQ", "list_date": null, "is_fin": false, "roles": {"fin": false, "commodity": false, "precious": false, "regulated": false, "hard": false, "growth": true}, "province": null, "main_business": "", "introduction": "", "close": 59.01, "pe_ttm": 18.556, "pb": 7.93, "dv_ttm": 0.0, "total_mv": 1462159.764492, "trade_date": "20260904", "years": ["最近年报"], "multi_year": false, "period": "最近年报", "gm_series": [96.4], "rev_series": [23.2], "np_series": [7.8], "roe_series": [35.5], "rev_ttm": 23.2, "np_ttm": 8.6, "ocf_ttm": 11.8, "fcf_ttm": null, "fcf_yield": null, "ocf_yield": 8.1, "gm_median": 96.4, "gm_std": null, "gm_stab": null, "gm_chg_2022": null, "npm_median": 33.7, "roe_median": 35.5, "commodity": false, "hard_ratio": 8.9, "fix_assets": 2.6, "hard_note": "PP&E 毛额 × 0.5 近似净额", "goodwill_ratio": null, "pb_calc": null, "capex_dep": null, "interest_debt": null, "debt_ebitda": null, "ebitda": 9.2, "debt_ratio": 24.0, "debt_mv": null, "payout": 0.0, "div_years": 0, "rev_cagr3": null, "np_cagr3": null, "rev_yoy": 7.0, "np_yoy": 50.1, "np_vol": null, "loss_years": 0, "far_share": 73.0, "earn_yield": 5.4, "consensus_n": 0, "fwd_pe": null, "fwd_pe2": null, "fwd_g1": null, "fwd_g2": null, "peg": null, "consensus_disp": null, "mainbz": [], "ret_prev_year": null, "ret_prev2_year": null, "ret_pivot": null, "prev_year": "", "prev2_year": "", "ret_ytd": 34.6, "ret_20": 9.1, "ret_60": 12.2, "ret_120": 43.7, "ret_250": 56.6, "mdd_250": null, "vol_250": null, "pos_52w": 98.8, "eps": 2.78}, "S": {"duration": 37, "pricing": 80, "hard": 14, "bondness": 13}, "label": "定价权·品牌", "tags": ["成长兑现", "轻资产现金牛"], "text": {"像什么": ["没有硬资产(固定资产占比 9%)但有定价权:毛利率最新年报 96.4%、ROE 最新年报 35.5%。", "经营现金流/市值 8.1%,分红率 0%,分子跟得上通胀。"], "为什么(不)算钱的替代品": "只占定价权一条(毛利率 96.4%),硬资产占比 9%。分子能跟上通胀,但没有重置成本对冲;按'定价权·品牌'看,不按硬资产看。", "加息期怎么走": "分子跟得上通胀、久期不长,加息期抗跌;放水期弹性不如科技。属船票一侧的'非债券'部分。", "四问": [["当前 FCF 能覆盖多少市值?", "经营现金流/市值 8.1%(futu 无资本开支,FCF 按经营现金流 × 0.7 近似)。覆盖高。"], ["能否每年提价而不掉量?", "毛利率最新年报 96.4%。能。"], ["资产重置成本随通胀涨吗?", "固定资产占总资产 9%。没有资产可言。"], ["估值里多少来自 5 年后的故事?", "按 PE 18.6 倍 粗算,约 73%(1 − 5/PE)。>70%,把 5 年后的假设砍一半,这个股票值多少钱?"]], "价格行为": "近一年 57%,现价在 52 周高点的 99%;近 20 / 60 / 120 日 9% / 12% / 44%。", "行业对照": ["同富途行业「生物技术」593 家中位:PE 13.7 / 股息率 0.0% / 毛利率 80.5% / 固定资产占比 5% / 分红率 0%。", "伊克力西斯:PE 比行业中位高 4.9倍;股息率 与行业中位持平;毛利率 比行业中位高 15.9个百分点;固定资产占比 比行业中位高 3.6个百分点。"]}}